15492322

Source:http://linkedlifedata.com/resource/pubmed/id/15492322

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0085542, umls-concept:C0118168, umls-concept:C0441471, umls-concept:C0681850, umls-concept:C0730345, umls-concept:C1280500, umls-concept:C1550501, umls-concept:C1706203, umls-concept:C2349001, umls-concept:C2697811
pubmed:issue	18
pubmed:dateCreated	2004-11-2
pubmed:abstractText	Microalbuminuria is associated with increased risk of cardiovascular events. We assessed whether therapeutic intervention aimed at lowering urinary albumin excretion would reduce cardiovascular events in microalbuminuric subjects (15 to 300 mg/24 hours).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Fosinopril, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1524-4539
pubmed:author	pubmed-author:AsselbergsFolkert WFW, pubmed-author:DiercksGilles F HGF, pubmed-author:HillegeHans LHL, pubmed-author:JanssenWilbert M TWM, pubmed-author:Prevention of Renal and Vascular Endstage Disease Intervention Trial..., pubmed-author:VoorsAdriaan AAA, pubmed-author:de JongPaul EPE, pubmed-author:de ZeeuwDickD, pubmed-author:van BovenAd JAJ, pubmed-author:van GilstWiek HWH, pubmed-author:van VeldhuisenDirk JDJ
pubmed:issnType	Electronic
pubmed:day	2
pubmed:volume	110
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2809-16
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15492322-Adult, pubmed-meshheading:15492322-Aged, pubmed-meshheading:15492322-Albuminuria, pubmed-meshheading:15492322-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15492322-Cardiovascular Diseases, pubmed-meshheading:15492322-Cohort Studies, pubmed-meshheading:15492322-Double-Blind Method, pubmed-meshheading:15492322-Female, pubmed-meshheading:15492322-Follow-Up Studies, pubmed-meshheading:15492322-Fosinopril, pubmed-meshheading:15492322-Hospitalization, pubmed-meshheading:15492322-Humans, pubmed-meshheading:15492322-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15492322-Incidence, pubmed-meshheading:15492322-Life Tables, pubmed-meshheading:15492322-Male, pubmed-meshheading:15492322-Middle Aged, pubmed-meshheading:15492322-Pravastatin, pubmed-meshheading:15492322-Treatment Outcome
pubmed:year	2004
pubmed:articleTitle	Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
pubmed:affiliation	Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't